Last updated: May 26, 2026
SMOFLIPID 20% (SMOFlipid) is a soy-MCT-olive-fish oil lipid emulsion used as a source of calories in parenteral nutrition. The supply chain is dominated by the original manufacturer/brand holder and its authorized distributors in each geography; no credible, complete global supplier roster can be produced from public data in a way that is accurate for all markets.
Who supplies SMOFLIPID 20% (SMOFlipid) to hospitals and wholesalers?
Featured snippet answer: SMOFLIPID 20% is supplied through the brand holder’s commercial organization and its authorized distribution network (country-specific), with product manufactured under the brand’s manufacturing sites and then distributed by local wholesalers.
What entities typically sit in the SMOFLIPID distribution chain?
- Marketing authorization holder / brand owner (global commercial ownership varies by country).
- Local MAH or authorized distributor (wholesaler relationships and hospital tenders are region-specific).
- Hospital pharmacy distribution channels (tender contracts, group purchasing, and consignment supply).
- Tender re-supply partners (authorized logistics and cold-chain warehousing providers, where applicable).
Why “supplier” lists vary by country
SMOFLIPID 20% is not distributed uniformly across geographies. In practice, the same brand may appear with different “brand owner” entities on local packaging and different distributor names across EU member states, the UK, and the US.
Which manufacturers make the SMOFLIPID 20% active lipid emulsion?
Featured snippet answer: SMOFLIPID 20% is manufactured by the brand’s proprietary lipid-emulsion process using SMOFlipid oil components (soybean oil, MCT, olive oil, and fish oil) under the marketing authorization.
What “manufacturers” means for pharma procurement
For procurement, the relevant “supplier” is usually the marketing authorization holder and its manufacturing sites listed on the label and in regulatory filings, not commodity oil suppliers.
What to look for in label/regulatory listings
- Manufacturer / release site named on the carton and package insert
- MAH name for the specific country
- Batch release and GMP site information
What are the key geographic differences in SMOFLIPID 20% suppliers?
Featured snippet answer: Suppliers are country-specific; procurement typically tracks the local MAH/distributor and tender contract, not a single global supplier.
EU and UK procurement pattern
- Distribution is commonly routed via country wholesalers under authorization.
- Hospital supply depends on tender awards and local distributor service levels.
US procurement pattern
If SMOFLIPID 20% is marketed in the US under the SMOFlipid brand, sourcing is typically through:
- The US MAH and appointed distributors, then
- Wholesalers (hospital accounts, GPO channels).
How to identify the correct SMOFLIPID 20% supplier for a specific tender
Featured snippet answer: Match the product you are buying to the exact country label MAH/distributor, since supplier identity changes with geography.
Procurement checklist
- Confirm country-specific carton label and NDC/pack presentation (where applicable).
- Confirm marketing authorization holder on the label.
- Use the distributor name appearing on the invoice/packing slip.
- Verify batch/lot documentation and storage requirements from the local product insert.
What generic or alternative competitors change the SMOFLIPID supply landscape?
Featured snippet answer: Competition does not usually reduce SMOFLIPID supplier numbers, but it changes tender behavior when substitutes are acceptable in nutrition therapy.
Typical substitution categories tender committees consider
- 20% lipid emulsions with alternative compositions (non-identical oil blends)
- Mixed fat emulsions vs single-source (soy, MCT/soy blends, olive-based emulsions, fish-oil-containing emulsions)
Key Takeaways
- SMOFLIPID 20% supply is handled through the brand holder and authorized, country-specific distribution networks.
- “Supplier” identity changes by market because MAH/distributor names and tender contracts are country-dependent.
- For procurement and contracting, the correct approach is to identify the country label MAH/distributor tied to the exact packaging you will receive.
FAQs
-
What distributor name should appear on SMOFLIPID 20% invoices in my country?
Use the distributor/authorized wholesaler shown on the country-specific label and packing documents for the batch you are ordering.
-
Are there multiple approved sources for SMOFLIPID 20% production?
Manufacturing is tied to named GMP sites under the product’s marketing authorization; those sites can vary by jurisdiction and regulatory listing.
-
Can hospitals switch from SMOFLIPID 20% to an equivalent lipid emulsion without changing suppliers?
They can switch clinically and contractually, but supplier identity and availability will follow the new product tender and its distribution network.
-
What documentation should procurement require for SMOFLIPID 20% orders?
Lot/batch traceability, COA, and the batch-specific storage and handling instructions from the local product information.
-
Do group purchasing organizations (GPOs) affect who supplies SMOFLIPID 20%?
Yes. GPO contracting often determines the authorized distributor eligible for hospital accounts, even if the underlying brand is unchanged.
References
- (No cited sources provided in the prompt.)
